Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (131-140 of 290) with videos related to

Pageof 29
Sort By:
International Journal of Hematology|May 18, 2010
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reportsTatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, et al.
Blood|June 2, 2009
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarityJianmin Ding, Hirokazu Komatsu, Shinsuke Iida, et al.
International Journal of Hematology|March 18, 2019
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantationHirokazu Sasaki, Sachiko Mitani, Shigeru Kusumoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 21, 2024
Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapyTakahiro Nakashima, Shigeru Kusumoto, Takashi Ishida, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
International Journal of Hematology|May 26, 2005
Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study GroupChihiro Shimazaki, Hiroshi Fujii, Takashi Yoshida, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood Advances|May 21, 2020
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphomaMasato Saito, Toshihiko Ishii, Itaru Urakawa, et al.
Blood Cancer Journal|May 2, 2018
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX studyKenshi Suzuki, Meletios A Dimopoulos, Naoki Takezako, et al.
Oncogene|July 27, 2005
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myelomaAtsushi Suzuki, Shinsuke Iida, Miyuki Kato-Uranishi, et al.
Pageof 29

Showing results (131-140 of 290) with videos related to

Sort By:
Pageof 29
International Journal of Hematology|May 18, 2010
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reportsTatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, et al.
Blood|June 2, 2009
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarityJianmin Ding, Hirokazu Komatsu, Shinsuke Iida, et al.
International Journal of Hematology|March 18, 2019
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantationHirokazu Sasaki, Sachiko Mitani, Shigeru Kusumoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 21, 2024
Fulminant hepatitis in a hepatitis B surface antigen-positive patient with adult T-cell leukemia-lymphoma after mogamulizumab monotherapyTakahiro Nakashima, Shigeru Kusumoto, Takashi Ishida, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
International Journal of Hematology|May 26, 2005
Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study GroupChihiro Shimazaki, Hiroshi Fujii, Takashi Yoshida, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Blood Advances|May 21, 2020
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphomaMasato Saito, Toshihiko Ishii, Itaru Urakawa, et al.
Blood Cancer Journal|May 2, 2018
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX studyKenshi Suzuki, Meletios A Dimopoulos, Naoki Takezako, et al.
Oncogene|July 27, 2005
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myelomaAtsushi Suzuki, Shinsuke Iida, Miyuki Kato-Uranishi, et al.
Pageof 29